Brought to you by 
Nestle boosts personalized nutritionals initiative with Prometheus buy
06 Jun 2011
Executive Summary
In a deal that one Bank Vontobel analyst estimated at $567mm-1bn, Nestle Health Science SA, a newly formed division of Nestle SA, has acquired privately held Prometheus Laboratories Inc. (drug and diagnostic in-licenser).
Deal Industry
- In Vitro Diagnostics
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com